AROVELLA THERAPEUTICS
Arovella Therapeutics is a bio technology company that offers therapies to treat oncology and the nervous system.
AROVELLA THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Oncology
Founded:
1999-01-01
Address:
Perth, Western Australia, Australia
Country:
Australia
Website Url:
http://www.arovella.com
Total Employee:
11+
Status:
Active
Contact:
61 8 6142 5555
Email Addresses:
[email protected]
Technology used in webpage:
Euro Pound Sterling Squarespace Hosted
Similar Organizations
AEterna Zentaris
AEterna Zentaris is a drug development company that specializes in oncology and endocrine therapy.
Agile Sciences
Agile Sciences is a biotechnology company that provides commercial solutions to the biopharma industry.
Xilio Therapeutics
Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
NBE-Therapeutics
NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Spectrum Pharmaceuticals
Spectrum Pharmaceuticals is a biopharmaceutical company developing drugs to treat oncology and hematology.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.arovella.com Semrush global rank: 10.8 M Semrush visits lastest month: 199
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Arovella Therapeutics"
Arovella Therapeutics - Crunchbase Company Profile & Funding
Organization. Arovella Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Arovella Therapeutics is a bio technology …See details»
Mission Statement — Arovella Therapeutics ASX: ALA
[email protected] +61.3.9863.6472. Subscribe to our Newsletters. Email Address. Sign Up. Thank you for joining the database for Arovella Therapeutics - we will contact you with upcoming investor relation news.See details»
Arovella | VentureRadar
Arovella Therapeutics (ASX: ALA) is a biotechnology company dedicated to advancing its innovative invariant Natural Killer T (iNKT) cell therapy platform for cancer treatment. ... Dansk …See details»
Arovella Therapeutics - Annual Report
Arovella's invariant Natural Killer T (iNKT) cell therapy platform is a novel, differentiated cancer therapeutic with the potential to treat various blood cancers and solid tumours. iNKT cells are …See details»
For personal use only - asx.com.au
In February, Arovella was accepted to present a poster at the American for Cancer Association Research’s (AACR) Annual Meeting held in April 2023. The AACR is the first and largest …See details»
Clinical Advisory Board established — Arovella Therapeutics ASX: …
Oct 14, 2024 Arovella is pleased to announce the appointment of three key opinion leaders and clinical oncologists to establish its Clinical Advisory Board (CAB). The CAB will provide expert …See details»
ALA-101 CONFERS SIGNIFICANT ANTI-TUMOUR EFFECT AND …
Apr 17, 2023 Arovella Therapeutics Limited ACN 090 987 250 Suite 1, Level 3, 62 Lygon Street, Carlton South, VIC 3053 Australia PO Box 655, Carlton South, VIC 2053 Australia Telephone: …See details»
3 For personal use only investor@arovella - Australian Securities …
Jan 11, 2023 Arovella Therapeutics Limited ACN 090 987 250 Suite 1, Level 3, 62 Lygon Street, Carlton South , VIC 3053 Australia PO Box 655, Carlton South, VIC 2053 Australia Telephone: …See details»
Arovella - VentureRadar
Arovella Therapeutics (ASX: ALA) is a biotechnology company focused on developing therapies to treat human disease. Our two focus areas are oncology and conditions that impact the …See details»
AROVELLA THERAPEUTICS LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AROVELLA THERAPEUTICS LIMITED of PRESTON, VICTORIA. Get the latest business insights from …See details»
Arovella Therapeutics Company Profile 2024: Stock Performance ...
Arovella Therapeutics General Information Description. Arovella Therapeutics Ltd is a biotechnology company focused on developing its invariant natural killer T (iNKT) cell therapy …See details»
Arovella Therapeutics - Contacts, Employees, Board Members, …
Organization. Arovella Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Number of Board …See details»
Arovella Therapeutics - Overview, News & Similar companies
Arovella Therapeutics contact info: Phone number: +61 861425555 Website: www.arovella.com What does Arovella Therapeutics do? Arovella Therapeutics intends to be a world leader as a …See details»
AROVELLA COMPLETES $1. 65M PLACEMENT For personal use only
Jan 19, 2023 Arovella Therapeutics Limited ACN 090 987 250 Suite 1, Level 3, 62 Lygon Street, Carlton South, VIC 3053 Australia PO Box 655, Carlton South, VIC 2053 Australia Telephone: …See details»
Mission Statement — Arovella Therapeutics ASX: ALA
At Arovella, we are invested in making a positive difference in helping patients live longer and healthier lives. Creating a brighter future for people is our driving force. Data-Driven and …See details»
Arovella Therapeutics to raise funds for trial of lymphoma drug
Mar 26, 2024 Arovella chairman Dr Thomas Duthy said: “This is a pivotal time for Arovella, which continues to be a global pioneer in developing CAR-iNKT cell therapeutics. “The level of …See details»
Arovella Therapeutics Ltd. - Diamond Equity Research
Arovella Therapeutics is a biotechnology company that has licensed novel cancer immunotherapies in early development phase. Focusing on the development of the therapies …See details»
Dr Michael Baker interviewed by JustStocks — Arovella …
Oct 22, 2024 Arovella Therapeutics Ltd (ASX:ALA) CEO Dr Michael Baker caught up with JustStocks Video following news the company has appointed three key opinion leaders and …See details»
Arovella Therapeutics to Release Shares from Escrow - Nasdaq
6 days ago Arovella Therapeutics Limited is set to release 413,379 Ordinary Shares from voluntary escrow on January 3, 2025. These shares were initially issued in exchange for …See details»
ESG Reports — Arovella Therapeutics ASX: ALA
[email protected] +61.3.9863.6472. Subscribe to our Newsletters. Email Address. Sign Up. Thank you for joining the database for Arovella Therapeutics - we will contact you with …See details»